Taking this into consideration, our results may suggest that reducing the availability of glutamine to the CD4+ cells might have beneficial effect on reducing T cells promoting autoimmunity by decreasing pathogenic CCR6 and CXCR3 bearing T cell and increasing regulatory T cells. The gene discussed is CCR6; the disease is Autoimmunity.